Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 76

1.

Tamoxifen enhances therapeutic effects of gemcitabine on cholangiocarcinoma tumorigenesis.

Jing G, Yuan K, Turk AN, Jhala NC, Arnoletti JP, Zhang K, McDonald JM, Chen Y.

Lab Invest. 2011 Jun;91(6):896-904. doi: 10.1038/labinvest.2011.60. Epub 2011 Apr 4.

2.

Molecular mechanisms of tamoxifen therapy for cholangiocarcinoma: role of calmodulin.

Pawar P, Ma L, Byon CH, Liu H, Ahn EY, Jhala N, Arnoletti JP, McDonald JM, Chen Y.

Clin Cancer Res. 2009 Feb 15;15(4):1288-96. doi: 10.1158/1078-0432.CCR-08-1150.

3.

Tamoxifen (TMX)/Fas induced growth inhibition of human cholangiocarcinoma (HCC) by gamma interferon (IFN-gamma).

Vickers SM, Jhala NC, Ahn EY, McDonald JM, Pan G, Bland KI.

Ann Surg. 2002 Jun;235(6):872-8.

4.

Calmodulin antagonists promote TRA-8 therapy of resistant pancreatic cancer.

Yuan K, Yong S, Xu F, Zhou T, McDonald JM, Chen Y.

Oncotarget. 2015 Sep 22;6(28):25308-19. doi: 10.18632/oncotarget.4490.

5.

Enhanced effect of gemcitabine by emodin against pancreatic cancer in vivo via cytochrome C-regulated apoptosis.

Chen H, Wei W, Guo Y, Liu A, Tong H, Wang Z, Tan W, Liu J, Lin S.

Oncol Rep. 2011 May;25(5):1253-61. doi: 10.3892/or.2011.1174. Epub 2011 Feb 3.

PMID:
21305255
6.

The novel histone deacetylase inhibitor, N-hydroxy-7-(2-naphthylthio) hepatonomide, exhibits potent antitumor activity due to cytochrome-c-release-mediated apoptosis in renal cell carcinoma cells.

Park KC, Heo JH, Jeon JY, Choi HJ, Jo AR, Kim SW, Kwon HJ, Hong SJ, Han KS.

BMC Cancer. 2015 Jan 23;15:19. doi: 10.1186/s12885-014-1003-1.

7.

A novel polysaccharide, isolated from Angelica sinensis (Oliv.) Diels induces the apoptosis of cervical cancer HeLa cells through an intrinsic apoptotic pathway.

Cao W, Li XQ, Wang X, Fan HT, Zhang XN, Hou Y, Liu SB, Mei QB.

Phytomedicine. 2010 Jul;17(8-9):598-605. doi: 10.1016/j.phymed.2009.12.014. Epub 2010 Jan 25.

PMID:
20092988
8.

SL-01, an oral gemcitabine derivative, inhibited human cancer growth more potently than gemcitabine.

Zhao C, Yue B, Liu H, Sun C, Li W, Qu X.

Toxicol Appl Pharmacol. 2012 Aug 1;262(3):293-300. doi: 10.1016/j.taap.2012.05.006. Epub 2012 May 19.

PMID:
22617428
10.

Metformin potentiates the anticancer activities of gemcitabine and cisplatin against cholangiocarcinoma cells in vitro and in vivo.

Zhu HQ, Ma JB, Song X, Gao HJ, Ma CQ, Chang H, Li HG, Liu FF, Lu J, Zhou X.

Oncol Rep. 2016 Dec;36(6):3488-3496. doi: 10.3892/or.2016.5187. Epub 2016 Oct 20.

PMID:
27779693
12.

Combination chemotherapy with gemcitabine and biotherapy with opioid growth factor (OGF) enhances the growth inhibition of pancreatic adenocarcinoma.

Zagon IS, Jaglowski JR, Verderame MF, Smith JP, Leure-Dupree AE, McLaughlin PJ.

Cancer Chemother Pharmacol. 2005 Nov;56(5):510-20. Epub 2005 Jun 10.

PMID:
15947928
13.

Involvement of human micro-RNA in growth and response to chemotherapy in human cholangiocarcinoma cell lines.

Meng F, Henson R, Lang M, Wehbe H, Maheshwari S, Mendell JT, Jiang J, Schmittgen TD, Patel T.

Gastroenterology. 2006 Jun;130(7):2113-29.

PMID:
16762633
14.

Caspase-3 mediates retinoid-induced apoptosis in the organogenesis-stage mouse limb.

Ali-Khan SE, Hales BF.

Birth Defects Res A Clin Mol Teratol. 2003 Oct;67(10):848-60.

PMID:
14745938
15.

Resistance of pancreatic cancer to gemcitabine treatment is dependent on mitochondria-mediated apoptosis.

Schniewind B, Christgen M, Kurdow R, Haye S, Kremer B, Kalthoff H, Ungefroren H.

Int J Cancer. 2004 Mar 20;109(2):182-8.

16.
17.

Calcitriol enhances gemcitabine anti-tumor activity in vitro and in vivo by promoting apoptosis in a human pancreatic carcinoma model system.

Yu WD, Ma Y, Flynn G, Muindi JR, Kong RX, Trump DL, Johnson CS.

Cell Cycle. 2010 Aug 1;9(15):3022-9. doi: 10.4161/cc.9.15.12381. Epub 2010 Aug 17.

18.

Equol induces apoptosis through cytochrome c-mediated caspases cascade in human breast cancer MDA-MB-453 cells.

Choi EJ, Ahn WS, Bae SM.

Chem Biol Interact. 2009 Jan 15;177(1):7-11. doi: 10.1016/j.cbi.2008.09.031. Epub 2008 Oct 9.

PMID:
18973749
19.
20.

Supplemental Content

Support Center